Christopher Gromisch
Pre-Doctoral Trainee
Boston University School of Medicine, Graduate Medical Sciences
Dept of Biochemistry






Development of a novel Antibody Drug Conjugate for the treatment of pancreatic cancer
08/01/2018 - 07/31/2021 (PI)
NIH/National Cancer Institute
1F30CA220843-01A1




Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Wong CK, Gromisch C, Ozturk S, Papageorgis P, Abdolmaleky HM, Reinhard BM, Thiagalingam A, Thiagalingam S. MicroRNA-4417 is a tumor suppressor and prognostic biomarker for triple-negative breast cancer. Cancer Biol Ther. 2019 Mar 28; 1-8.View Related Profiles. PMID: 30922194.
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 1 publications over 1 distinct years, with a maximum of 1 publications in 2019

YearPublications
20191
Contact for Mentoring:


700 Albany St Ctr for Adv Biomed Res
Boston MA 02118
Google Map


Co-Authors
_
Same Department